Limiting Cost-sharing on Drugs: A Big PhRMA Objective from Health Reform
This article was originally published in RPM Report
Executive Summary
Preventing big out-of-pocket expenditures by patients for health services and pharmaceuticals may be the antidote to the toxic bad publicity for health reform during August. At least, PhRMA hopes so. The trade association is helping to support an AMA campaign against copays.